However, elevated adiponectin in established AD has also been reported, suggesting a compensatory increase or “adiponectin resistance” where receptor signaling is impaired despite ligand abundance, mirroring patterns seen with leptin in obesity [212,213]. This evidence concerns the gene ADIPOQ and Alzheimer disease.